ZBH — Zimmer Biomet Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- $24.54bn
- $29.90bn
- $7.39bn
- 95
- 36
- 77
- 79
2019 December 31st | C2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1,132 | -9.2 | 446 | 291 | 1,025 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 154 | 706 | 352 | 443 | 97.3 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -168 | -430 | -134 | -311 | -396 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | 1,586 | 1,205 | 1,499 | 1,285 | 1,582 |
Capital Expenditures | -721 | -371 | -417 | -446 | -689 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -8.7 | -243 | -86.4 | -83 | -89.7 |
Acquisition of Business | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -729 | -614 | -504 | -529 | -779 |
Financing Cash Flow Items | -25.3 | -100 | -173 | 466 | -26.1 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -780 | -422 | -1,306 | -844 | -764 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 75.1 | 184 | -324 | -103 | 40.1 |